RE: AstraZeneca12 Sep 2020 02:40
This is from a scientist friend who works for another major pharma. According to our president our strategy is to still execute growth in high impact innovation and emerging markets. Doesn’t say yet who we are after next. These company acquisitions can take a long time though because within pharma theres is a lot to negotiate on.
With the above in mind negotiations may have been happening this could have been going on for months already but all will become clearer in the AGM. The only thing I would say is GM has been clear about his plan of indication, R&D and acquisition, he’s also talked about long term strategy’s for growth to reward shareholders. Unless this is smoke an mirrors to keep share holders engaged whilst this goes on in the background.